Digital CardioEpi Lab retweeted
📢 New in JAMA Network Open:
In a multicenter EHR-based cohort of >23k adults, semaglutide initiation was linked to ↓ weight, BP, cholesterol & HbA1c — but ↑ health care expenditures (excluding drug cost).
Bridging trial evidence to real-world impact.
🔗 jamanetwork.com/journals/jam…
@YaleCardiology @DigitalCardiEpi @hmkyale @rohan_khera @Chungsoo_
Digital CardioEpi Lab retweeted
Just out in JAMA, we analyzed EHR data from 39M+ U.S. adults to understand uptake and disparities in semaglutide and tirzepatide prescribing for obesity (2021–2024). Only 2.3% of eligible adults received a prescription. @YaleCardiology @AniaJastreboff @hmkyale @Chungsoo_
Between 2021 and 2024, #semaglutide and #tirzepatide prescriptions in Epic-affiliated health care systems increased slightly but remained limited, with only 3% of eligible patients receiving them.
ja.ma/434WUBr
Digital CardioEpi Lab retweeted
Between 2021 and 2024, #semaglutide and #tirzepatide prescriptions in Epic-affiliated health care systems increased slightly but remained limited, with only 3% of eligible patients receiving them.
ja.ma/434WUBr
Digital CardioEpi Lab retweeted
The @JACCJournals collaboration w/ OHDSI opens incredible potential for the community to both publish global #RWE and educate on best practices in observational research. Thank you to @hmkyale, @SengChanYou1, Yuan Lu, @nicolepratt_ & @suchard_group on a great #OHDSI2024 panel!
Digital CardioEpi Lab retweeted
A #LEGENDary team leading our community. The work coming from our LEGEND team continues to guide how observational research can and should be done. It was a fabulous Q&A that provided a lot to think about for the future. #OHDSI2024 #JoinTheJourney
Digital CardioEpi Lab retweeted
Using EHR data from a large health system, we demonstrated a strong association between the social vulnerability index and cardiovascular events in hypertensive patients, identifying neighborhood-level hotspots.@hmkyale @Chungsoo_ @YaleCardiology @CouncilonHTN
#Hypertension24
Digital CardioEpi Lab retweeted
Our rising star @Chungsoo_ is discussing the real-world impact of semaglutide on cardiovascular risk factors. @CouncilonHTN @hmkyale @YaleCardiology
@DigitalCardiEpi #Hypertension24
Digital CardioEpi Lab retweeted
Does optimal blood pressure control lead to optimal longevity? It's crucial to adopt a holistic perspective on health outcomes. Glad to co-author this editorial with Dr. Yuan Ma from Harvard School of Public Health.@YaleCardiology
@DigitalCardiEpi
ahajournals.org/doi/10.1161/…
Digital CardioEpi Lab retweeted
Clinicians' adherence to medication guidelines is a complex and multifaceted process. In this qualitative study, we developed a pragmatic taxonomy of suboptimal adherence scenarios for severe hypertension. @hmkyale @YaleCardiology @DigitalCardiEpi jamanetwork.com/journals/jam…
Next Generation Research Uses Real-World Data to Identify Most Effective Hypertension Drugs for Patients led by Dr. Yuan Lu and our team!
medicine.yale.edu/core/news-…
Digital CardioEpi Lab retweeted
Using 12-year EHR data from Sentara, we showed trends in hypertension and disparities that mirror the results from NHANES. Timely EHR data allows rapid evaluation of populations at scale to inform strategies for improvement. @jeb1426 @hmkyale @YaleCardiology @DigitalCardiEpi
Analysis of our regional real-world data showed rising hypertension prevalence and persistent racial disparities, providing a local call to action. Our analysis could be a model for other health systems. #AHAJournals @jeb1426 @yuan_lu1 @hmkyale ahajrnls.org/44LYLKV
Digital CardioEpi Lab retweeted
Analysis of our regional real-world data showed rising hypertension prevalence and persistent racial disparities, providing a local call to action. Our analysis could be a model for other health systems. #AHAJournals @jeb1426 @yuan_lu1 @hmkyale ahajrnls.org/44LYLKV


















